```

[Federal Register Volume 88, Number 165 (Monday, August 28, 2023)]
[Notices]
[Pages 58585-58586]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18449]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Solicitation of Nominations for Appointment to the Lead Exposure 
and Prevention Advisory Committee

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), within 
the Department of Health and Human Services (HHS), is soliciting 
nominations for membership on the Lead Exposure and Prevention Advisory 
Committee (LEPAC). The LEPAC is composed of 15 members that are Federal 
and non-Federal experts in fields associated with lead screening, the 
prevention of lead exposure, and services for individuals and 
communities affected by lead exposure.

DATES: Nominations for membership on the LEPAC must be received no 
later than September 30, 2023. Packages received after this time will 
not be considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to [email protected].

FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H., 
Designated Federal Officer, National Center for Environmental Health, 
Centers for Disease Control and Prevention, 4770 Buford Highway, 
Atlanta, Georgia 30341. Telephone: 770-488-6774; Email: 
[email protected].

SUPPLEMENTARY INFORMATION:  Nominations are being sought for 
individuals with expertise in the fields of epidemiology, toxicology, 
mental health, pediatrics, early childhood education, special 
education, diet and nutrition, and environmental health. Members may be 
invited to serve for three-year terms. Selection of members is based on 
candidates' qualifications to contribute to the accomplishment of Lead 
Exposure and Prevention Advisory Committee (LEPAC) objectives.
    The members of this Committee are selected by the Secretary of the 
Department of Health and Human Services (HHS). The committee's 
objective is to advise the Secretary, HHS and the Director, Centers for 
Disease Control and Prevention (CDC)/Administrator, Agency for Toxic 
Substances and Disease Registry on a range of activities to include: 
(1) review of Federal programs and services available to individuals 
and communities exposed to lead; (2) review of the current research on 
lead exposure to identify additional research needs; (3) review of and 
identification of best practices, or the need for best practices 
regarding lead screening and the prevention of lead exposure; (4) 
identification of effective services, including services relating to 
healthcare, education, and nutrition for individuals and communities 
affected by lead exposure and lead poisoning, including in consultation 
with, as appropriate, the lead exposure registry as established in 
Public Law 114-322 section 2203(b) (42 U.S.C. 300j-27); and (5) 
undertaking of any other review or activities that the Secretary 
determines to be appropriate.
    Annually as determined necessary by the Secretary or as required by 
Congress, the committee shall submit a report to include: (1) an 
evaluation of the effectiveness of the Federal programs and services 
available to individuals and communities exposed to lead; (2) an 
evaluation of additional lead exposure research needs; (3) an 
assessment of any effective screening methods or best practices used or 
developed to prevent or screen for lead exposure; (4) input and 
recommendations for improved access to effective services relating to 
health care, education, or nutrition for

[[Page 58586]]

individuals and communities impacted by lead exposure; and (5) any 
other recommendations for communities affected by lead exposure, as 
appropriate.
    At least half of the committee will consist of Federal 
representatives from a range of agencies that may include the 
Department of Housing and Urban Development; the Environmental 
Protection Agency; the Consumer Product Safety Commission; the Centers 
for Medicare and Medicaid Services; the Health Resources and Services 
Administration; the Food and Drug Administration (FDA); the U.S. 
Department of Agriculture; the Occupational Safety and Health 
Administration; the National Institute of Environmental Health 
Sciences; the U.S. Geological Survey; and such additional Federal, 
state, tribal, and local public and private officials as the Secretary 
deems necessary for the committee to carry out its function. The rest 
of the committee will consist of non-Federal members. Only non-Federal 
members are being solicited with this announcement.
    HHS policy stipulates that committee membership be balanced in 
terms of points of view represented and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens and cannot be full-time employees of the 
U.S. Government. Current participation on Federal workgroups or prior 
experience serving on a Federal advisory committee does not disqualify 
a candidate; however, HHS policy is to avoid excessive individual 
service on advisory committees and multiple committee memberships. 
Committee members are Special Government Employees, requiring the 
filing of financial disclosure reports at the beginning and annually 
during their terms. CDC reviews potential candidates for LEPAC 
membership each year and provides a slate of nominees for consideration 
to the Secretary of HHS for final selection. HHS notifies selected 
candidates of their appointment as soon as the HHS selection process is 
completed. Note that the need for different expertise varies from year 
to year and a candidate who is not selected in one year may be 
reconsidered in a subsequent year.
    Candidates should submit the following items:
     Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
     At least one letter of recommendation from person(s) not 
employed by HHS. Candidates may submit letter(s) from current HHS 
employees if they wish, but at least one letter must be submitted by a 
person not employed by an HHS agency (e.g., CDC, National Institutes of 
Health, FDA).
    Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-18449 Filed 8-25-23; 8:45 am]
BILLING CODE 4163-18-P
```